Busić Zeljko, Cupurdija Kristijan, Kolovrat Marijan, Cavka Vlatka, Cavka Mislav, Patrlj Leonardo, Servis Drazen, Kvesić Ante
Department of Abdominal Surgery, University Hospital Dubrava, Zagreb, Croatia.
Coll Antropol. 2010 Mar;34 Suppl 1:287-90.
Solitary splenic metastases are very rare and sporadic. There are several explanations for this low incidence of splenic metastasis including anatomical, histological and immunological features of the spleen. In this paper we present a case of 70-year-old man with no history of previous diseases who was first operated under the diagnosis of acute abdomen revealing perforated colon tumor of splenic flexure with no metastases at that time. Left hemicolectomy was performed followed by postoperative complications demanding a subtotal colectomy and ileostomy. Primary tumor was classified as Dukes (Astler-Coller)-C2, T4NIMO. Patient was referred to oncologist and received chemotherapy (5FU, Leucovorin). 5 months later continuity of the gut was performed by ileosygmoanastomosis. 2 years after first surgical procedure, a CT scan and abdominal ultrasound, followed by needle biopsy, showed isolated metastasis in spleen, so splenectomy was performed. Pathological findings revealed sharply bordered, partially necrotic tumor inside of spleen tissue, spreading to, but not reaching splenic hilum. Histology showed low to medium differentiated adenocarcinoma tissue with desmoplastic stromal reaction. There were no protrusions of tumor cells through spleen surface. In splenic hilum 4 tumor free lymph nodes were harvested. No additional chemotherapy was conducted. The latest follow up, a year after diagnosis of metastasis showed no signs of cancer disease. Review of the literature showed that long term survival and prognosis of isolated splenic colorectal metastasis after splenectomy are rather optimistic, although these are the cases of distant metastasis. Due to small number of cases reported in literature, definitive conclusions and/or guidelines for the treatment of isolated splenic metastasis cannot be given, but splenectomy and chemotherapy are preferable in the treatment, promising long term survival at least for metachronous metastasis.
孤立性脾转移瘤非常罕见且呈散发性。脾转移发生率低有多种解释,包括脾脏的解剖学、组织学和免疫学特征。本文报告一例70岁男性患者,既往无疾病史,最初因急性腹痛接受手术,术中发现脾曲结肠肿瘤穿孔,当时无转移。行左半结肠切除术,术后出现并发症,需行次全结肠切除术和回肠造口术。原发肿瘤分类为Dukes(阿斯特勒 - 科勒)-C2,T4NIMO。患者转诊至肿瘤学家处并接受化疗(5-氟尿嘧啶、亚叶酸钙)。5个月后通过回肠乙状结肠吻合术恢复肠道连续性。首次手术2年后,CT扫描和腹部超声检查后进行穿刺活检,显示脾脏有孤立性转移,因此行脾切除术。病理检查发现脾脏组织内有边界清晰、部分坏死的肿瘤,蔓延至但未到达脾门。组织学显示为低至中度分化的腺癌组织,伴有促纤维组织增生性间质反应。肿瘤细胞未穿过脾表面突出。在脾门处采集了4个无肿瘤的淋巴结。未进行额外化疗。最新随访显示,转移诊断后一年无癌症疾病迹象。文献回顾表明,尽管是远处转移的情况,但脾切除术后孤立性结直肠癌脾转移的长期生存和预后相当乐观。由于文献报道的病例数量较少,无法给出关于孤立性脾转移治疗的明确结论和/或指南,但脾切除术和化疗在治疗中较为可取,有望至少为异时性转移带来长期生存。